Clinical Trial Update: Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer [Phase 1]

View source ↗

Summary

This is a Phase 1 trial evaluating Adriamycin (doxorubicin) plus cyclophosphamide followed by Abraxane as adjuvant therapy for breast cancer; the study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Adriamycin (doxorubicin)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Celgene Corporation | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED